Artelo Biosciences GAAP EPS of $3.97

* Artelo Biosciences press release [https://seekingalpha.com/pr/20303587-artelo-biosciences-provides-business-update-and-reports-third-quarter-2025-financial-results] (ARTL [https://seekingalpha.com/symbol/ARTL]): Q3 GAAP EPS of $3.97.
* In September 2025, the Company completed a confidentially marketed public offering of common stock with gross proceeds of $3.0 million.
*  

MORE ON ARTELO BIOSCIENCES

* Artelo Biosciences prices $2 million public offering; shares down over 24% [https://seekingalpha.com/news/4500185-artelo-biosciences-prices-2-million-public-offering-shares-down-over-24]
* Artelo Biosciences announces pricing of $3 million public offering [https://seekingalpha.com/news/4492297-artelo-biosciences-announces-pricing-of-3-million-public-offering]
* Seeking Alpha’s Quant Rating on Artelo Biosciences [https://seekingalpha.com/symbol/ARTL/ratings/quant-ratings]
* Financial information for Artelo Biosciences [https://seekingalpha.com/symbol/ARTL/income-statement]